Ubs Asset Management Americas Inc Myriad Genetics Inc Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 285,229 shares of MYGN stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285,229
Previous 198,256
43.87%
Holding current value
$3.15 Million
Previous $5.43 Million
27.94%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$168 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$117 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$66.4 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$61.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$48.1 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $892M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...